“…With the exception of epoxy peptide 29 , which was subjected to macrolactonization reaction conditions, following Yamaguchi methodology, the other precursors ( 34 , 41 , and 48 ) were exposed, under high dilution conditions, to a variety of coupling reagents, including diethyl cyanophosphonate (DEPC), diphenyl phosphoryl azide (DPPA), O- (7-azabenzotriazol-1-yl)- N , N , N ‘ , N ‘ -tetramethyluronium hexafluorophosphate/1-hydroxybenzotriazole (HATU/HOBt), O- (benzotriazol-1-yl)- N , N , N ‘ , N ‘ -tetramethyluronium hexafluorophosphate/HOBt (HBTU/HOBt), EDCI/HOBt, and pentafluorophenol/EDCI (PFP/EDCI), in different solvents (DCM, THF, DMF, MeCN). The results from these studies revealed that, whereas the macrolactonization did not work at all for compound 29 , resulting in a complex mixture of decomposition products, the macrolactamizations provided more positive results, especially with the epoxy peptide 34 , which afforded the best yields for the desired macrocycle 8 when it was treated with DPPA or DEPC as coupling reagents and DMF as solvent. The epoxy peptide that was obtained represents an interesting compound for the preparation of the 2,3-epoxy analogue of stevastelin B, as well as representing the direct precursor for the natural compound.…”